Sponsor of the Day:
Jerkmate
https://sleepreviewmag.com/sleep-disorders/circadian-rhythm-disorders/shift-work/drug-shows-promise-reducing-excessive-sleepiness-early-morning-shift-workers/
Drug Shows Promise for Reducing Excessive Sleepiness in Early Morning Shift Workers | Sleep Review
Apr 6, 2026 - A new clinical trial from Mass General Brigham found that a drug approved for other indications helped early morning shift workers with shift work disorder...
drug shows promiseearly morningsleep reviewreducingexcessive
https://www.diabetes.org.uk/about-us/news-and-views/type-1-beta-cell-therapy-and-drug-shows-promise-treat-type-2-march-2026-research
A step forward for type 1 beta cell therapy and drug shows promise to treat type 2: March 2026...
In this month's article:
drug shows promise2 march 2026step forwardtype 1beta cell
https://www.biopharmadive.com/news/revolution-aacr-2026-daraxonrasib-pancreatic-cancer-results/818173/
Revolution drug shows promise in early pancreatic cancer | BioPharma Dive
The findings build on data suggesting Revolution’s therapy could upend treatment for a notoriously tough-to-treat tumor and generate billions in sales.
drug shows promiseearly pancreatic cancerbiopharma diverevolution
https://www.livescience.com/health/groundbreaking-new-drug-shows-promise-for-treating-children-with-a-devastating-form-of-epilepsy
Groundbreaking new drug shows promise for treating children with a devastating form of epilepsy |...
Mar 5, 2026 - An experimental treatment reduces seizures and other symptoms in children with a type of epilepsy called Dravet syndrome.
drug shows promisegroundbreaking newtreatingchildrendevastating
https://www.statnews.com/2026/04/13/spyre-ibd-drug-success-early-trial/
Spyre Therapeutics inflammatory bowel disease drug shows promise in trial
Apr 13, 2026 - An inflammatory bowel disease treatment developed by Spyre Therapeutics sets the company up to compete with several large drugmakers.
inflammatory bowel diseasedrug shows promisespyretherapeuticstrial
https://winabetorg.com/general/semozboloraxid-breakthrough-anti-inflammatory-drug-shows-promise-in-clinical-trials/
Semozboloraxid: Breakthrough Anti-Inflammatory Drug Shows Promise in Clinical Trials - Winabetorg
Semozboloraxid represents a groundbreaking advancement in pharmaceutical research that’s transforming the treatment landscape for chronic inflammatory...
drug shows promisebreakthrough anticlinical trialsinflammatorywinabetorg